• Latest Posts

UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II

Galapagos Shoots Past its IPO in a New Public Round of €315M

Huge Successful €103M IPO for the Next European Leader in Bioplastics

Swedish Oncology Biotech makes a Large IPO for its Peptides

UPDATE: British Biotech Investment Company goes Public with €117M

French Biotech gets a Boost in the NASH Race with a Successful IPO

ADVERTISEMENT

Gene Therapy Biotech Founded to Save the CEO’s Daughter Goes Public in France

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

UPDATE: European Stem Cell Therapy Pioneer goes for €34M IPO

CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers

ADVERTISEMENT